Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,201
Closed -$219K 96
2024
Q4
$219K Buy
2,201
+69
+3% +$7.11K 0.09% 84
2024
Q3
$242K Buy
2,132
+466
+28% +$55.4K 0.1% 69
2024
Q2
$206K Sell
1,666
-28
-2% -$3.61K 0.09% 69
2024
Q1
$224K Buy
+1,694
New +$209K 0.11% 60
2023
Q4
Sell
-2,364
Closed -$243K 80
2023
Q3
$243K Buy
2,364
+503
+27% +$54.2K 0.14% 60
2023
Q2
$215K Buy
+1,861
New +$211K 0.13% 55

Other funds holding MRK

WorthPointe's MRK Position: Q1 2025 in Review

WorthPointe sold out of Merck (MRK) in Q1 2025, closing a stake of 2,201 shares — an estimated $219K sold.

WorthPointe first reported a position in MRK in Q2 2023 and held it in 6 quarters. The position peaked at $243K in Q3 2023. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • WorthPointe reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • WorthPointe sold 2,201 Merck shares in Q1 2025, an estimated $219K.
  • WorthPointe first reported a position in Merck in Q2 2023 and held it in 6 quarters.
  • WorthPointe's Merck position peaked at $243K in Q3 2023.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on WorthPointe's 13F filing for Q1 2025, filed 6 May 2025.